The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic evaluation of tumor mutational burden-high (TMB-H) versus TMB-low (TMB-L) metastatic breast cancer to reveal unique mutational features.
 
Sarah Sammons
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Foundation Medicine; Novartis; Sermonix Pharmaceuticals
Research Funding - Abbvie; AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly; Sermonix Pharmaceuticals
 
Andrew Elliott
Employment - Caris Life Sciences
 
Jeremy Meyer Force
Stock and Other Ownership Interests - Genomic Health
Consulting or Advisory Role - Exact Sciences
Speakers' Bureau - Genomic Health
 
Nicholas C. DeVito
No Relationships to Disclose
 
Paul Kelly Marcom
Consulting or Advisory Role - Genentech/Roche; Immunomedics
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); Glycomimetics (Inst); Millennium (Inst); Novartis (Inst); Verily (Inst)
 
Sandra M. Swain
Consulting or Advisory Role - AstraZeneca; Athenex; Beijing Medical Award Foundation; Beijing Medical Award Foundation; Daiichi Sankyo; Exact Sciences; Genentech/Roche; Inivata; Molecular Templates; Natera; Pieris Pharmaceuticals; Silverback Therapeutics
Research Funding - Genentech (Inst); Kailos Genetics (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences; Daichi-Sanyo; Genentech/Roche
Other Relationship - AstraZeneca; Roche
 
Antoinette R. Tan
Consulting or Advisory Role - Abbvie; Athenex; Celgene; Eisai; G1 Therapeutics; Genentech/Roche; immunomedics; Merck; Novartis
Research Funding - Daiichi Sankyo (Inst); Genentech/Roche (Inst); Merck (Inst); Pfizer (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Caris Centers of Excellence
 
Evanthia T. Roussos Torres
No Relationships to Disclose
 
Jia Zeng
Employment - Caris Life Sciences
 
Mustafa Khasraw
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Janssen; Lilly; Roche
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Specialised Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Justin M. Balko
Consulting or Advisory Role - Novartis
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Incyte
Patents, Royalties, Other Intellectual Property - FCRL6 as an immunotherapy target; Patent on use of HLA-DR/MHC expression to predict response to immunotherapies
Other Relationship - NanoString Technologies
 
Wolfgang Michael Korn
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Consulting or Advisory Role - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Carey K. Anders
Honoraria - AstraZeneca; Eisai; Elucida Oncology; Genentech/Roche; Immunomedics; IPSEN; Puma Biotechnology; Seagen
Consulting or Advisory Role - AstraZeneca; Eisai; Elucida Oncology; Genentech/Roche; Immunomedics; Ipsen; Puma Biotechnology; Seagen
Research Funding - G1 Therapeutics (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst); Tesaro (Inst); Zion Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Jones and Bartlett; Up to Date.com
Travel, Accommodations, Expenses - Eisai